Reaction
Therapeutic Reaction Time Decreased reporting signals
As of the last recalculation, Therapeutic Reaction Time Decreased appears in 2,904 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is VEDOLIZUMAB (PRR 4,046.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vedolizumab | 2,741 | 4,046.1 | 4,179.9 |
| Mesalamine | 432 | 64.6 | 65.1 |
| Cholestyramine | 41 | 24.6 | 24.7 |
| Loperamide Hydrochloride And Dimethicone | 71 | 16.2 | 16.3 |
| Azathioprine | 185 | 16.0 | 16.0 |
| Diphenoxylate Hydrochloride And Atropine Sulfate | 28 | 14.8 | 14.8 |
| Psyllium Husk | 20 | 14.6 | 14.6 |
| Pantoprazole Sodium In 0.9% Sodium Chloride | 112 | 13.4 | 13.5 |
| Pantoprazole Sodium Injection | 112 | 13.4 | 13.4 |
| Iron | 119 | 13.3 | 13.3 |
| Budesonide | 105 | 13.2 | 13.2 |
| Prednisone | 681 | 12.4 | 12.4 |
| Loperamide Hydrochloride | 74 | 12.1 | 12.2 |
| Dimenhydrinate | 16 | 10.8 | 10.8 |
| Rabeprazole | 33 | 10.8 | 10.8 |
| Dexlansoprazole | 57 | 10.0 | 10.0 |
| Hydrocortisone Sodium Succinate | 10 | 7.6 | 7.7 |
| Dicyclomine Hydrochloride | 15 | 7.6 | 7.6 |
| Ciclesonide | 14 | 7.4 | 7.4 |
| Methimazole | 8 | 7.3 | 7.3 |
| Pantoprazole | 230 | 7.0 | 7.0 |
| Calcium | 138 | 6.9 | 6.9 |
| Candesartan | 34 | 6.9 | 6.9 |
| Indapamide | 16 | 6.4 | 6.4 |
| Pantoprazole Sodium | 116 | 5.8 | 5.8 |
| Instalax Polyethylene Glycol 3350 | 9 | 5.2 | 5.2 |
| Polyethylene Glycol 400 | 9 | 5.1 | 5.1 |
| Progesterone | 16 | 5.0 | 5.0 |
| Mercaptopurine | 12 | 5.0 | 5.0 |
| Lisdexamfetamine Dimesylate | 22 | 4.8 | 4.8 |
| Brinzolamide | 5 | 4.1 | 4.1 |
| Oral Semaglutide | 32 | 3.1 | 3.1 |
| Vortioxetine | 7 | 3.0 | 3.0 |
| Cannabidiol | 9 | 2.8 | 2.8 |